ERBB2 and breast cancer: Because trastuzumab can enhance Th1 cell-mediated antitumor immunity [16, 58, 62], and miR-19a-3p regulates T cell functions, we investigated the association between the levels of miR-19a-3p and immune responses in HER2 + breast cancer.